These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9430448)

  • 1. Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly.
    Cuttica CM; Giusti M; Bocca L; Sessarego P; De Martini D; Valenti S; Spaziante R; Giordano G
    Neuroendocrinology; 1997 Dec; 66(6):426-31. PubMed ID: 9430448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide stimulates growth hormone secretion from human fetal pituitaries and cultured pituitary adenomas.
    Rubinek T; Rubinfeld H; Hadani M; Barkai G; Shimon I
    Endocrine; 2005 Nov; 28(2):209-16. PubMed ID: 16388095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly.
    Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly.
    Cuttica CM; Sessarego P; Ponzani P; Falivene MR; Valenti S; De Martini D; Giusti M
    Recenti Prog Med; 1997 Jun; 88(6):264-8. PubMed ID: 9233053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
    Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
    J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
    Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
    J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endogenous growth hormone-releasing hormone in acromegaly.
    Dimaraki EV; Chandler WF; Brown MB; Jaffe CA; Kim SY; Taussig R; Padmanabhan V; Barkan AL
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2185-90. PubMed ID: 16537684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
    Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):601-11. PubMed ID: 2512040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures.
    Vankelecom H; Matthys P; Denef C
    Mol Cell Endocrinol; 1997 May; 129(2):157-67. PubMed ID: 9202399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
    Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.